According to the World Heath Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...

DEAR PEOPLE’S PHARMACY: My father has severe COPD. The doctors at the Department of Veterans Affairs hospital prescribed ...

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken ...

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease state characterized by airflow limitation that is not fully reversible.

Chronic obstructive pulmonary disease causes 2.5 times more deaths in men than in women. From 2001 to 2019, mortality due to that pathology declined by 43% in men and women.

Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) diseases that cause breathing difficulty and coughing. Asthma affects about ...

During monsoon season, respiratory infections, allergies, and chronic respiratory disorders including asthma and chronic ...

Astegolimab from Roche's Genentech fails phase 3 COPD trial, reflecting challenges in monoclonal antibody treatment for the ...

How gum disease aggravates chronic obstructive pulmonary disease. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 01 / 240114212121.htm ...